Cargando…

Complete Response of Chemo-Refractory Metastatic Metaplastic Breast Cancer to Paclitaxel-Immunotherapy Combination

Patient: Female, 49 Final Diagnosis: Metastatic metaplastic breast cancer Symptoms: Progressive right breast mass Medication: 5-fluorouracil • Cytoxan • Epirubicin (FEC 100) • Docetaxel • Capecitabine Clinical Procedure: Mastectomy • Radiation Therapy Specialty: Oncology OBJECTIVE: Rare disease BACK...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al Sayed, Adher D., Elshenawy, Mahmoud A., Tulbah, Asma, Al-Tweigeri, Taher, Ghebeh, Hazem
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858626/ https://www.ncbi.nlm.nih.gov/pubmed/31690713 http://dx.doi.org/10.12659/AJCR.918770

Ejemplares similares

Weekly Paclitaxel given concurrently with Durvalumab has a favorable safety profile in triple-negative metastatic breast cancer
por: Ghebeh, Hazem, et al.
Publicado: (2021)

FOXP3(+ )T(regs )and B7-H1(+)/PD-1(+ )T lymphocytes co-infiltrate the tumor tissues of high-risk breast cancer patients: Implication for immunotherapy
por: Ghebeh, Hazem, et al.
Publicado: (2008)

Impact of Pathologic Complete Response following Neoadjuvant Chemotherapy ± Trastuzumab in Locally Advanced Breast Cancer
por: Al-Tweigeri, Taher, et al.
Publicado: (2021)

Fascin Is a Key Regulator of Breast Cancer Invasion That Acts via the Modification of Metastasis-Associated Molecules
por: Al-Alwan, Monther, et al.
Publicado: (2011)

Bidirectional crosstalk between PD-L1 expression and epithelial to mesenchymal transition: Significance in claudin-low breast cancer cells
por: Alsuliman, Abdullah, et al.
Publicado: (2015)

β1 Integrin is essential for fascin‐mediated breast cancer stem cell function and disease progression
por: Barnawi, Rayanah, et al.
Publicado: (2019)

Higher PD-L1 Immunohistochemical Detection Signal in Frozen Compared to Matched Paraffin-Embedded Formalin-Fixed Tissues
por: Ghebeh, Hazem, et al.
Publicado: (2021)

Association Between Neutrophil-Lymphocyte Ratio and Oncotype Dx Recurrence Score in Early-Stage Hormonal Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer
por: Alshamsan, Bader, et al.
Publicado: (2021)

Being 40 or younger is an independent risk factor for relapse in operable breast cancer patients: The Saudi Arabia experience
por: Elkum, Naser, et al.
Publicado: (2007)

Dramatic response of metaplastic breast cancer to chemo-immunotherapy
por: Adams, Sylvia
Publicado: (2017)

Doxorubicin downregulates cell surface B7-H1 expression and upregulates its nuclear expression in breast cancer cells: role of B7-H1 as an anti-apoptotic molecule
por: Ghebeh, Hazem, et al.
Publicado: (2010)

Towards targeting PD-1/PD-L1 axis in breast cancer, pre-clinical data
por: Ghebeh, Hazem, et al.
Publicado: (2015)

Clinical Identification of Dysregulated Circulating microRNAs and Their Implication in Drug Response in Triple Negative Breast Cancer (TNBC) by Target Gene Network and Meta-Analysis
por: Qattan, Amal, et al.
Publicado: (2021)

Association Between Obesity and Clinicopathological Profile of Patients with Newly Diagnosed Non-Metastatic Breast Cancer in Saudi Arabia
por: Alshamsan, Bader, et al.
Publicado: (2022)

High DNMT1 Expression in Stromal Fibroblasts Promotes Angiogenesis and Unfavorable Outcome in Locally Advanced Breast Cancer Patients
por: Al-Kharashi, Layla A., et al.
Publicado: (2022)

Single-Institute Review of HER-2/Neu-Positive Invasive Lobular Breast Carcinoma in an Arab Population
por: Osmani, Asif Husain, et al.
Publicado: (2021)

Fascin is involved in the chemotherapeutic resistance of breast cancer cells predominantly via the PI3K/Akt pathway
por: Ghebeh, H, et al.
Publicado: (2014)

Clinical and functional significance of tumor/stromal ATR expression in breast cancer patients
por: Al-Ansari, Mysoon M., et al.
Publicado: (2020)

Profiling of normal and malignant breast tissue show CD44(high)/CD24(low) phenotype as a predominant stem/progenitor marker when used in combination with Ep-CAM/CD49f markers
por: Ghebeh, Hazem, et al.
Publicado: (2013)

The molecular significance of methylated BRCA1 promoter in white blood cells of cancer-free females
por: Al-Moghrabi, Nisreen, et al.
Publicado: (2014)

High AUF1 level in stromal fibroblasts promotes carcinogenesis and chemoresistance and predicts unfavorable prognosis among locally advanced breast cancer patients
por: Al-Tweigeri, Taher, et al.
Publicado: (2022)

Lymphocyte function and response to chemo-immunotherapy in patients with metastatic melanoma.
por: Thatcher, N., et al.
Publicado: (1977)

Immunotherapy Combined with Chemotherapy in Relapse Metaplastic Breast Cancer
por: Chen, Ling, et al.
Publicado: (2023)

Complete remission of chemo‐refractory multiple‐metastatic upper tract urothelial carcinoma by autologous formalin‐fixed tumor vaccine
por: Miyoshi, Tatsu, et al.
Publicado: (2017)

A Case of Metaplastic Squamous Cell Carcinoma of the Breast that Showed a Pathological Complete Response After Neoadjuvant Chemotherapy with Weekly Paclitaxel
por: Noro, Aya, et al.
Publicado: (2022)

Translational Implications of Dysregulated Pathways and microRNA Regulation in Quadruple-Negative Breast Cancer
por: Qattan, Amal, et al.
Publicado: (2022)

Metaplastic carcinoma of the breast: an immunohistochemical study
por: Altaf, Fadwa J, et al.
Publicado: (2014)

Towards safety of oral anti-cancer agents, the need to educate our pharmacists
por: Mekdad, Sanaa Saeed, et al.
Publicado: (2017)

Patterns of Care and Survival of Metastatic Metaplastic Breast Cancer Patients
por: Youssef, Irini, et al.
Publicado: (2020)

Metastatic Metaplastic Breast Cancer Successfully Treated with Adriamycin and Cisplatin
por: Hayashino, Kenta, et al.
Publicado: (2022)

Age-Specific Gene Expression Signatures for Breast Tumors and Cross-Species Conserved Potential Cancer Progression Markers in Young Women
por: Colak, Dilek, et al.
Publicado: (2013)

Complete Pathological Response After Neoadjuvant Chemo-Immunotherapy in Malignant Pleural Mesothelioma
por: Tostes, Francinne T., et al.
Publicado: (2022)

Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer
por: Asaduzzaman, Muhammad, et al.
Publicado: (2017)

Complete Response of Triple-Negative Metaplastic Carcinoma of the Breast Using Pembrolizumab
por: Ladwa, Amrita, et al.
Publicado: (2023)

Neurogranin Regulates Metaplasticity
por: Zhong, Ling, et al.
Publicado: (2020)

Squamous Cell Differentiation in Metastatic Papillary Thyroid Carcinoma: Metaplastic Reversion or Progression?
por: Handra-Luca, Adriana
Publicado: (2018)

Case Report: Pathological Complete Response in a Brain-Metastatic Lung Squamous Cell Carcinoma Patient With Long-Term Benefit From Chemo-Immunotherapy
por: Hu, Chen, et al.
Publicado: (2021)

Transcriptomic alterations underlying metaplasia into specific metaplastic components in metaplastic breast carcinoma
por: Lien, Huang-Chun, et al.
Publicado: (2023)

Differential expression of PD-L1 between primary and metastatic epithelial ovarian cancer and its clinico-pathological correlation
por: Parvathareddy, Sandeep Kumar, et al.
Publicado: (2021)

Metaplastic Breast Carcinoma: Experience of a Tertiary Cancer Center in the Middle East
por: Erjan, Ayah, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j8472d8lacfcvngkiek91tgnqn